Springer - Drug Resistance in Leukemia and Lymphoma III

Cellular drug resistance remains a significant obstacle to successful chemotherapy for patients with leukemia and lymphoma. This medical text addresses the urgent need to connect laboratory research with clinical application to improve patient outcomes. As part of the Advances in Experimental Medicine and Biology series, this volume provides essential insights for scientists and clinicians working in oncology. This book contains the complete proceedings from the third International Symposium on Drug Resistance in Leukemia and Lymphoma, held in Amsterdam, The Netherlands. By compiling research from these specialized meetings, the text offers a comprehensive look at the various aspects of drug resistance. It serves as a vital resource for medical professionals and researchers looking to understand the mechanisms behind treatment limitations and explore new directions in hematologic oncology research.